• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

因治疗技术而产生的皮肤问题与 1 型糖尿病患者的疾病负担增加有关。

Skin Problems Due to Treatment with Technology Are Associated with Increased Disease Burden Among Adults with Type 1 Diabetes.

机构信息

1 University of Copenhagen, Copenhagen, Denmark.

2 Steno Diabetes Center Copenhagen, Gentofte, Denmark.

出版信息

Diabetes Technol Ther. 2019 Apr;21(4):215-221. doi: 10.1089/dia.2019.0007.

DOI:10.1089/dia.2019.0007
PMID:30943072
Abstract

BACKGROUND

In a 4-month follow-up survey, we examined whether treatment with continuous subcutaneous insulin infusion (CSII) and/or continuous glucose monitoring (CGM) in adults with type 1 diabetes was associated with sustained skin problems and whether skin problems were associated with diabetes-related emotional distress.

RESEARCH DESIGN AND METHODS

A total of 111 adult patients completed a follow-up questionnaire concerning skin problems as a result of CSII and/or CGM use. The questionnaire included a patient-reported outcome measure, the Problem Areas in Diabetes (PAID) scale.

RESULTS

Current visible skin problems caused by CSII or CGM use were reported by 51 (46.0%) participants, in 34 (66.7%) of whom skin problems had been reported more than 4 months earlier. Seventy-two (64.9%) participants reported skin problems as a result of CSII use, whereas 38 (74.5%) reported skin problems owing to CGM use at some time. Itching was the most prevalent complaint. CSII-related itching was associated with a mean PAID score >20 (P = 0.01), and patients with more than one skin problem had an increased PAID score compared with those with one or no skin problems (P = 0.006).

CONCLUSIONS

More than half patients treated with CSII, CGM, or both had experienced skin problems during 4 months of follow-up that were associated with increased diabetes burden. Skin problems represent a persistent health issue affecting diabetes-specific emotional distress.

摘要

背景

在一项为期 4 个月的随访调查中,我们研究了成人 1 型糖尿病患者接受持续皮下胰岛素输注(CSII)和/或连续血糖监测(CGM)治疗是否与持续的皮肤问题相关,以及皮肤问题是否与糖尿病相关的情绪困扰相关。

研究设计和方法

共有 111 名成年患者完成了一份关于 CSII 和/或 CGM 使用导致皮肤问题的随访问卷。该问卷包括一个患者报告的结果测量,即糖尿病问题领域(PAID)量表。

结果

51 名(46.0%)参与者报告了目前由 CSII 或 CGM 使用引起的可见皮肤问题,其中 34 名(66.7%)参与者在 4 个月前就报告了皮肤问题。72 名(64.9%)参与者报告了 CSII 使用引起的皮肤问题,而 38 名(74.5%)参与者在某些时候报告了 CGM 使用引起的皮肤问题。瘙痒是最常见的投诉。CSII 相关的瘙痒与平均 PAID 评分>20 相关(P=0.01),且与只有一个或没有皮肤问题的患者相比,有多个皮肤问题的患者的 PAID 评分更高(P=0.006)。

结论

在 4 个月的随访期间,超过一半接受 CSII、CGM 或两者治疗的患者经历了与糖尿病负担增加相关的皮肤问题。皮肤问题是一个持续存在的健康问题,会影响糖尿病相关的情绪困扰。

相似文献

1
Skin Problems Due to Treatment with Technology Are Associated with Increased Disease Burden Among Adults with Type 1 Diabetes.因治疗技术而产生的皮肤问题与 1 型糖尿病患者的疾病负担增加有关。
Diabetes Technol Ther. 2019 Apr;21(4):215-221. doi: 10.1089/dia.2019.0007.
2
Skin Problems Associated with Insulin Pumps and Sensors in Adults with Type 1 Diabetes: A Cross-Sectional Study.成人 1 型糖尿病患者的胰岛素泵和传感器相关皮肤问题:一项横断面研究。
Diabetes Technol Ther. 2018 Jul;20(7):475-482. doi: 10.1089/dia.2018.0088. Epub 2018 Jun 12.
3
Prevalence and Description of the Skin Reactions Associated with Adhesives in Diabetes Technology Devices in an Adult Population: Results of the CUTADIAB Study.成人糖尿病技术设备中与粘合剂相关的皮肤反应的患病率及描述:CUTADIAB研究结果
Diabetes Technol Ther. 2023 Apr;25(4):279-286. doi: 10.1089/dia.2022.0513. Epub 2023 Feb 24.
4
Cutaneous Reactions to Continuous Glucose Monitoring and Continuous Subcutaneous Insulin Infusion Devices in Type 1 Diabetes Mellitus.1 型糖尿病患者的连续血糖监测和连续皮下胰岛素输注装置的皮肤反应。
J Diabetes Sci Technol. 2021 Jul;15(4):786-791. doi: 10.1177/1932296820918894. Epub 2020 May 9.
5
[Current status of continuous subcutaneous insulin infusion and continuous glucose monitoring systems in the Community of Madrid].[马德里自治区皮下胰岛素持续输注及血糖连续监测系统的现状]
Endocrinol Nutr. 2015 Apr;62(4):171-9. doi: 10.1016/j.endonu.2015.01.003. Epub 2015 Feb 26.
6
Comparison of Insulin Pump Therapy and Multiple Daily Injections Insulin Regimen in Patients with Type 1 Diabetes During Ramadan Fasting.斋月禁食期间1型糖尿病患者胰岛素泵治疗与多次皮下注射胰岛素方案的比较
Diabetes Technol Ther. 2017 Jun;19(6):349-354. doi: 10.1089/dia.2016.0418. Epub 2017 Mar 15.
7
Comparison of Different Treatment Modalities for Type 1 Diabetes, Including Sensor-Augmented Insulin Regimens, in 52 Weeks of Follow-Up: A COMISAIR Study.1型糖尿病不同治疗方式的比较,包括传感器增强胰岛素治疗方案,随访52周:COMISAIR研究
Diabetes Technol Ther. 2016 Sep;18(9):532-8. doi: 10.1089/dia.2016.0171. Epub 2016 Aug 2.
8
Nonmetabolic complications of continuous subcutaneous insulin infusion: a patient survey.持续皮下胰岛素输注的非代谢并发症:患者调查。
Diabetes Technol Ther. 2014 Mar;16(3):145-9. doi: 10.1089/dia.2013.0192. Epub 2013 Nov 1.
9
High frequencies of dermatological complications in children using insulin pumps or sensors.儿童使用胰岛素泵或传感器时,皮肤并发症的频率较高。
Pediatr Diabetes. 2018 Jun;19(4):733-740. doi: 10.1111/pedi.12652. Epub 2018 Feb 26.
10
Educating families on real time continuous glucose monitoring: the DirecNet navigator pilot study experience.对家庭进行实时连续血糖监测教育:DirecNet导航仪试点研究经验
Diabetes Educ. 2009 Jan-Feb;35(1):124-35. doi: 10.1177/0145721708325157.

引用本文的文献

1
A deep learning framework for virtual continuous glucose monitoring and glucose prediction based on life-log data.基于生活日志数据的虚拟连续血糖监测与血糖预测深度学习框架。
Sci Rep. 2025 May 10;15(1):16290. doi: 10.1038/s41598-025-01367-7.
2
A Cross-Sectional Study Demonstrating a High Prevalence of Skin Rash to Diabetes Medical Devices: An Underestimated Problem.一项横断面研究表明糖尿病医疗设备引起皮疹的患病率很高:一个被低估的问题。
J Diabetes Sci Technol. 2025 May 7:19322968251336261. doi: 10.1177/19322968251336261.
3
Allergic contact dermatitis caused by glucose sensors and insulin pumps: A full review: Part 1: Sensors and pumps, adverse cutaneous reactions, allergens, and diabetes devices causing allergic contact dermatitis.
葡萄糖传感器和胰岛素泵引起的过敏性接触性皮炎:全面综述:第1部分:传感器和泵、皮肤不良反应、过敏原以及导致过敏性接触性皮炎的糖尿病设备
Contact Dermatitis. 2025 Feb;92(2):87-112. doi: 10.1111/cod.14698. Epub 2024 Nov 26.
4
Navigating the Unique Challenges of Automated Insulin Delivery Systems to Facilitate Effective Uptake, Onboarding, and Continued Use.应对自动胰岛素输送系统的独特挑战,以促进有效采用、引入和持续使用。
J Diabetes Sci Technol. 2025 Jan;19(1):47-53. doi: 10.1177/19322968241275963. Epub 2024 Aug 30.
5
First International Survey on Diabetes Providers' Assessment of Skin Reactions in Youth With Type 1 Diabetes Using Technological Devices.关于糖尿病医护人员对1型糖尿病青少年使用技术设备时皮肤反应评估的首次国际调查。
J Diabetes Sci Technol. 2025 May;19(3):666-672. doi: 10.1177/19322968231206155. Epub 2023 Oct 17.
6
Experience with burdens of diabetes device use that affect uptake and optimal use in people with type 1 diabetes.1型糖尿病患者使用糖尿病设备的负担体验,这些负担会影响设备的采用率和最佳使用情况。
Endocr Connect. 2023 Sep 8;12(10). doi: 10.1530/EC-23-0193. Print 2023 Oct 1.
7
A Concise and Systematic Review on Non-Invasive Glucose Monitoring for Potential Diabetes Management.无创血糖监测在潜在糖尿病管理中的简明系统综述。
Biosensors (Basel). 2022 Nov 3;12(11):965. doi: 10.3390/bios12110965.
8
Diabetes Technology Meeting 2021.2021 年糖尿病技术会议。
J Diabetes Sci Technol. 2022 Jul;16(4):1016-1056. doi: 10.1177/19322968221090279. Epub 2022 May 2.
9
Technologies for Type 1 Diabetes and Contact Dermatitis: Therapeutic Tools and Clinical Outcomes in a Cohort of Pediatric Patients.1 型糖尿病和接触性皮炎的技术:儿科患者队列中的治疗工具和临床结果。
Front Endocrinol (Lausanne). 2022 Mar 15;13:846137. doi: 10.3389/fendo.2022.846137. eCollection 2022.
10
Evaluation of Extended Infusion Set Performance in Adults with Type 1 Diabetes: Infusion Set Survival Rate and Glycemic Outcomes from a Pivotal Trial.评估 1 型糖尿病成人中延长输注套件的性能:一项关键性试验中的输注套件存活率和血糖结果。
Diabetes Technol Ther. 2022 Aug;24(8):535-543. doi: 10.1089/dia.2021.0540. Epub 2022 Mar 24.